Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study

Background and Objectives: Intravenous recombinant tissue plasminogen activator (rt-PA) has been approved for acute ischemic stroke (AIS) within 3 h after onset and the treatment was then extended to 4.5 h. However, the Food and Drug Administration did not approve the indication in the expanded time...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Chen, Yu-Wei, Sung, Sheng-Feng, Chen, Chih-Hung, Tang, Sung-Chun, Tsai, Li-Kai, Lin, Huey-Juan, Huang, Hung-Yu, Po, Helen L., Sun, Yu, Chen, Po-Lin, Chan, Lung, Wei, Cheng-Yu, Lee, Jiunn-Tay, Hsieh, Cheng-Yang, Lin, Yung-Yang, Yeh, Shoou-Jeng, Lien, Li-Ming, Jeng, Jiann-Shing
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803783/
https://ncbi.nlm.nih.gov/pubmed/31681138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2019.01038
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados